Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Sarepta Therapeutics, Inc.
About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, siRNA knockdown therapies, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. The Company has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS.
Find out what a historical investment in Sarepta Therapeutics, Inc. would be worth today using our SRPT stock calculator.
Market Capitalisation
$1.76B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.29M
High today
$17.26
Low today
$16.58
Open price
$16.79
52-week high
$44.14
52-week low
$10.42
Ready to start your investing journey with Stake?
Open an accountHow do I buy SRPT shares in Australia?
Buying SRPT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Sarepta Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SRPT
What is the ticker symbol of Sarepta Therapeutics, Inc.?
The ticker symbol for Sarepta Therapeutics, Inc. is SRPT.
How much is one share of SRPT?
One share of SRPT is valued at $17.12 as of 20 May 2026.
What is the market capitalisation of Sarepta Therapeutics, Inc. SRPT?
As of 20 May 2026 Sarepta Therapeutics, Inc. has a market cap of $1.76B.
What is the P/E ratio of SRPT?
The Price to Earnings ratio of SRPT is 153.15.
What is the Earnings Per Share of SRPT?
The Earnings Per Share of SRPT is $0.11.
What is the 52-week high for Sarepta Therapeutics, Inc. stock?
The Sarepta Therapeutics, Inc. 52-week high stock price is $44.14.
What is the 52-week low for Sarepta Therapeutics, Inc. stock?
The Sarepta Therapeutics, Inc. 52-week low stock price is $10.42.
Can I buy SRPT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SRPT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SRPT on Stake
- Buy SRPT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SRPT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SRPT related stocks